NZ's AFT Pharmaceuticals eyes best day in 5 weeks on HY results
** Shares of AFT Pharmaceuticals AFT.NZ rise as much as
1.83% to NZ$3.340, their highest since Nov. 14
** Stock set for best day since Oct 18, if gains hold
** Drugmaker posts HY net profit after tax of NZ$1.8 mln
($1.08 mln), up 17%
** HY operating revenue NZ$84 mln, up 27%
** Co says FY24 forecast for operating profit of NZ$22 mln
to NZ$24 mln unchanged
** Stock down 10% this year, as of last close
($1 = 1.6700 New Zealand dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))
Recent news on AFT Pharmaceuticals
See all newsNZ's AFT Pharma eyes highest weekly gain in over 2 months after results
Brief: AFT Pharmaceuticals Reports Double Digit Revenue Growth In 1H FY27
NZ's AFT Pharmaceuticals gains most in over 2 weeks on strong half-year results
Brief: AFT Pharmaceuticals Enters Exclusive Development, License And Supply Agreement With Mikasaseiyaku
NZ's AFT Pharma rises to near 1-month high on Japan licensing deal for Maxigesic IV